To access the full text documents, please follow this link: http://hdl.handle.net/20.500.12328/1374
dc.contributor.author | Berenguera, Anna |
---|---|
dc.contributor.author | Pujol-Ribera, Enriqueta |
dc.contributor.author | Rodriguez-Blanco, Teresa |
dc.contributor.author | Violan, Concepció |
dc.contributor.author | Casajuana Closas, Marc |
dc.contributor.author | De Kort, Nelleke |
dc.contributor.author | Trapero Bertran, Marta |
dc.date | 2019-12-05T09:48:19Z |
dc.date | 2019-12-05T09:48:19Z |
dc.date | 2011-08-22 |
dc.identifier | Berenguera, Anna; Pujol-Ribera, Enriqueta; Rodriguez-Blanco, Teresa et al. «Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial». BMC Musculoskeletal Disorders, 2011, vol. 12, art. 194. Disponible en: <https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/1471-2474-12-194>. Fecha de acceso: 05 dic. 2019. DOI: 10.1186/1471-2474-12-194 |
dc.identifier | 1471-2474 |
dc.identifier | https://doi.org/10.1186/1471-2474-12-194 |
dc.identifier.uri | http://hdl.handle.net/20.500.12328/1374 |
dc.description | Background Low back pain (LBP), with high incidence and prevalence rate, is one of the most common reasons to consult the health system and is responsible for a significant amount of sick leave, leading to high health and social costs. The objective of the study is to assess the cost-effectiveness and cost-utility analysis of a multidisciplinary biopsychosocial educational group intervention (MBEGI) of non-specific sub-acute LBP in comparison with the usual care in the working population recruited in primary healthcare centres. Methods/design The study design is a cost-effectiveness and cost-utility analysis of a MBEGI in comparison with the usual care of non-specific sub-acute LBP. Measures on effectiveness and costs of both interventions will be obtained from a cluster randomised controlled clinical trial carried out in 38 Catalan primary health care centres, enrolling 932 patients between 18 and 65 years old with a diagnosis of non-specific sub-acute LBP. Effectiveness measures are: pharmaceutical treatments, work sick leave (% and duration in days), Roland Morris disability, McGill pain intensity, Fear Avoidance Beliefs (FAB) and Golberg Questionnaires. Utility measures will be calculated from the SF-12. The analysis will be performed from a social perspective. The temporal horizon is at 3 months (change to chronic LBP) and 12 months (evaluate the outcomes at long term). Assessment of outcomes will be blinded and will follow the intention-to-treat principle. Discussion We hope to demonstrate the cost-effectiveness and cost-utility of MBEGI, see an improvement in the patients' quality of life, achieve a reduction in the duration of episodes and the chronicity of non-specific low back pain, and be able to report a decrease in the social costs. If the intervention is cost-effectiveness and cost-utility, it could be applied to Primary Health Care Centres. |
dc.format | 9 |
dc.format | application/pdf |
dc.language | eng |
dc.publisher | BMC |
dc.relation | BMC Musculoskeletal Disorders |
dc.relation | 12;194 |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.subject | Cost effectiveness |
dc.subject | Cost-eficàcia |
dc.subject | Análisis coste-beneficio |
dc.subject | Esquena--Malalties |
dc.subject | Back--Diseases |
dc.subject | Dorsalgia |
dc.subject | 33 |
dc.subject | 61 |
dc.title | Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |